Sun Pharmaceutical Industries Q2 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,804.65
6.85 (0.38%)
6.85 (0.38%)Volume27.81 K
Updated: Mon 25 Nov, 2024 | 15:48:46
NSE
1,81014.70 (0.82%)
14.70 (0.82%)Volume3.14 M
Updated: Mon 25 Nov, 2024 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹13,291.39 Cr.(5.05%)
- Operating Profit₹3,184.96 Cr.(6.06%)
- Profit After Tax₹3,040.16 Cr.(7.21%)
- Operating Margin23.96%(13.21%)
Note: Comparison is on YoY basis
Quarterly - Sun Pharmaceutical Industries Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 13,291.39 | 11,940.84 | -% | 12,192.41 | -% |
| Selling/ General/ Admin Expenses Total | 2,477.70 | 2,402.04 | -% | 2,364.36 | -% |
| Depreciation/ Amortization | 625.91 | 651.32 | -% | 632.82 | -% |
| Other Operating Expenses Total | 4,308.62 | 3,450.90 | -% | 3,827.49 | -% |
| Total Operating Expense | 10,106.43 | 9,585.30 | -% | 9,611.76 | -% |
| Operating Income | 3,184.96 | 2,355.54 | -% | 2,580.65 | -% |
| Net Income Before Taxes | 3,597.88 | 2,481.14 | -% | 2,790.88 | -% |
| Net Income | 3,040.16 | 2,022.54 | -% | 2,375.51 | -% |
| Diluted Normalized EPS | 12.70 | 9.49 | -% | 9.90 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST